Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

VEGF impact on synaptic alterations in Alzheimer's disease ; Impact du VEGF sur les altérations synaptiques dans la maladie d’Alzheimer

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Institut NeuroMyoGène (INMG); Université Claude Bernard Lyon 1 (UCBL); Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS); Université de Lyon; Claire Meissirel
    • بيانات النشر:
      CCSD
    • الموضوع:
      2018
    • Collection:
      Université de Lyon: HAL
    • نبذة مختصرة :
      Alzheimer disease (AD) is characterized by a progressive decline in cognitive abilities. Amyloid-ß oligomers (Aßo) trigger synapse dysfunction through defects in glutamate receptor function and subsequent dendritic spine loss. These synaptic impairments compromise memory and contribute to cognitive deficits.Our recent findings revealed that VEGF facilitates synaptic plasticity and memory in mice through its VEGFR2 receptor in neurons. We showed that VEGF promotes glutamate receptor synaptic insertion and stimulates dendritic spine formation, suggesting it may be a key candidate for alleviating synapse damage in AD.Our objective is to study the role of VEGF in synapse protection in AD models and unravel the underlying mechanisms.First, we examined the VEGF expression pattern in postmortem brain tissue from AD patients and APPPS1 model of AD. Our results showed a partial colocalization between VEGF and Aß plaques in AD patients and APPPS1 brains.To further investigate the Aß-VEGF interaction, we used Elisa assay and peptide arrays and demonstrated that Aßo binds several domains of VEGF, impedding VEGFR2 activation.Finally, we examined whether VEGF can prevent synapse damage induced by Aßo using electrophysiological, biochemical and 3D modelling approaches. Our results demonstrated that VEGF treatments can restore LTP in Aßo-treated hippocampal slices, glutamate receptor content at synapses and increase dendritic spine density.All together, our results suggest that Aß-VEGF interaction may alter VEGF pathway in AD and that VEGF reduces Aßo-induced toxicity at synapses by modulating glutamate receptor expression and promoting spine formation and/or stabilization ; La maladie d’Alzheimer est caractérisée par un déclin progressif des capacités cognitives. Les Aßo induisent des dysfonctionnements de la transmission via une altération des récepteurs au glutamate et une perte de synapses.Nos récents résultats démontrent que le VEGF facilite la plasticité synaptique et la mémoire chez des souris via son action sur son ...
    • Relation:
      NNT: 2018LYSE1265
    • الدخول الالكتروني :
      https://theses.hal.science/tel-02127969
      https://theses.hal.science/tel-02127969v1/document
      https://theses.hal.science/tel-02127969v1/file/TH2018MARTINLAURENT.pdf
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.E3A608D8